New technique for the emergent repositioning of the displaced Impella device

To the Editor, The use of circulatory support has grown exponentially over the last decade, particularly for the management of cardiogenic shock in the setting of acute myocardial infarction.1,2 The devices more often used like the Impella CP (Abiomed, United States) show good results in observation...

Full description

Saved in:
Bibliographic Details
Published inREC, Interventional cardiology (Internet. English ed.) Vol. 3; no. 3; pp. 221 - 223
Main Authors García-Carreño, Jorge, Bastante, Teresa, Gutiérrez-Ibañes, Enrique, Eugenia Vázquez, María, Alfonso, Fernando, Fernández-Avilés, Francisco
Format Journal Article
LanguageEnglish
Published Permanyer 01.07.2021
Online AccessGet full text

Cover

More Information
Summary:To the Editor, The use of circulatory support has grown exponentially over the last decade, particularly for the management of cardiogenic shock in the setting of acute myocardial infarction.1,2 The devices more often used like the Impella CP (Abiomed, United States) show good results in observational studies. These studies describe an improved survival rate when these devices are used as part of a well-defined program to treat cardiogenic shock.3-5 However, this is not a risk-free therapy, and device displacement is a complication that can occur while the patient is being moved or transferred. Although rare, this complication can be deadly if not solved immediately because there is a loss of hemodynamic support. In these cases, the device needs to be retrieved due to the impossibility of crossing the aortic valve to proceed with a new implant.
ISSN:2604-7322
2604-7322
DOI:10.24875/RECICE.M20000156